Gerrit-Jan Liefers

5PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2025
Ribociclib-Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01).

Anne F de Groot, Danielle Cohen, Joan B Heijns

|May 06, 2025
Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα.

Els M E Verdegaal, Anique L C Verpoorte, Monique K van der Kooij

|Mar 27, 2025
Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index.

Marie-France Jilderda, Yi Zhang, Valerie Rebattu

|Feb 03, 2022
Revising the Role of Integrin Subunit β4 Expression in Colon Cancer Progression and Survival.

Eva Rademaker, Esther Bastiaannet, Jan Oosting

|Sep 14, 2019
Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based Study.

Anna Z de Boer, Heleen C van der Hulst, Nienke A de Glas

Pageof 1